Analysis of ESR1 and PIK3CA mutations in plasma cell-free DNA from ER-positive breast cancer patients.

about

Analysis of differential gene expression profile identifies novel biomarkers for breast cancer.Are We Ready to Use ESR1 Mutations in Clinical Practice?The predictive ability of plasma mutations for the efficacy of endocrine therapy in hormone-receptor-positive advanced breast cancer

P2860

Q49188421-E0E19C84-E3CA-4102-B316-C9485BC926C7 Q49885951-8196EE7D-3CF5-4BA5-8C03-6EF2E704D15F Q57073414-2B92F0FB-045E-4902-975C-0B3DB2FEC6BD

P2860

Analysis of ESR1 and PIK3CA mutations in plasma cell-free DNA from ER-positive breast cancer patients.

Item

http://www.wikidata.org/entity/Q40503471

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Analysis of ESR1 and PIK3CA mu ...... sitive breast cancer patients.

@en

type

Item

label

Analysis of ESR1 and PIK3CA mu ...... sitive breast cancer patients.

@en

prefLabel

Analysis of ESR1 and PIK3CA mu ...... sitive breast cancer patients.

@en

P1476

Analysis of ESR1 and PIK3CA mu ...... sitive breast cancer patients.

@en

P2093

Aiko Sueta

http://www.w3.org/2001/XMLSchema#string

Hirotaka Iwase

http://www.w3.org/2001/XMLSchema#string

Keiichi Murakami

http://www.w3.org/2001/XMLSchema#string

Mai Tomiguchi

http://www.w3.org/2001/XMLSchema#string

Mutsuko Yamamoto-Ibusuki

http://www.w3.org/2001/XMLSchema#string

Yoko Omoto

http://www.w3.org/2001/XMLSchema#string

Yutaka Yamamoto

http://www.w3.org/2001/XMLSchema#string

P2860

Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts

Liquid biopsies: genotyping circulating tumor DNA

ESR1 ligand-binding domain mutations in hormone-resistant breast cancer.

PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma

The life history of 21 breast cancers

Breast cancer version 3.2014.

Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer.

Multiplex Detection of Rare Mutations by Picoliter Droplet Based Digital PCR: Sensitivity and Specificity Considerations

Reproducibility of Digital PCR Assays for Circulating Tumor DNA Analysis in Advanced Breast Cancer

Kinetics, prognostic and predictive values of ESR1 circulating mutations in metastatic breast cancer patients progressing on aromatase inhibitor

P304

52142-52155

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.18479

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Takashi Takeshita

P577

2017-06-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28881720

http://www.w3.org/2001/XMLSchema#string

P932

5581019

http://www.w3.org/2001/XMLSchema#string

Analysis of ESR1 and PIK3CA mutations in plasma cell-free DNA from ER-positive breast cancer patients.

about

P2860

P2860

Analysis of ESR1 and PIK3CA mutations in plasma cell-free DNA from ER-positive breast cancer patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932